{"id":"NCT00827983","sponsor":"IBSA Institut Biochimique SA","briefTitle":"Subcutaneous Progesterone Versus Vaginal Progesterone Gel for Luteal Phase Support in Patients Undergoing In-Vitro Fertilization (IVF)","officialTitle":"Efficacy and Tolerability of Subcutaneous Progesterone Versus Vaginal Progesterone Gel for Luteal Phase Support in Patients Undergoing In-Vitro Fertilization (IVF)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-01","primaryCompletion":"2010-11","completion":"2011-05","firstPosted":"2009-01-23","resultsPosted":"2012-12-26","lastUpdate":"2013-01-31"},"enrollment":683,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["In Vitro Fertilization"],"interventions":[{"type":"DRUG","name":"Progesterone","otherNames":[]},{"type":"DRUG","name":"Progesterone","otherNames":[]}],"arms":[{"label":"Progesterone SC","type":"EXPERIMENTAL"},{"label":"Progesterone Vaginal gel","type":"ACTIVE_COMPARATOR"}],"summary":"Prospective, open, randomised, parallel, multicentre, two arm trial comparing a new form of luteal support (S.C.) to an approved comparator (vaginal gel).","primaryOutcome":{"measure":"Ongoing Pregnancy Rate at the End of the Study","timeFrame":"10 weeks after treatment start","effectByArm":[{"arm":"Progesterone SC","deltaMin":27.4,"sd":null},{"arm":"Progesterone Vaginal Gel","deltaMin":30.5,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.37"}]},"eligibility":{"minAge":"18 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":19},"locations":{"siteCount":14,"countries":["Germany","Hungary","Italy","Switzerland","United Kingdom"]},"refs":{"pmids":["30895243","24140033"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":14,"n":338},"commonTop":["Administration site pain","vaginal hemorrage","Uterine spasm","Administration site pruritus","vaginal discharge"]}}